← Evidence map

ArticleOncoTargets and therapy2017

miR-17 as a diagnostic biomarker regulates cell proliferation in breast cancer.

Fangliang Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

22 papers cite it

2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 28203087